GenoGenix LLC recalls NAD+ (Nicotinamide adenine dinucleotide) for Injection
FDA Class I
FDA classified this recall as Class I: the most serious kind, meaning there is a reasonable chance the product could cause serious health problems or death.
- Hazard
- Microbial Contamination of Sterile Products: elevated endotoxin levels
- Products
-
- NAD+ (Nicotinamide adenine dinucleotide) for Injection
- Company
- GenoGenix LLC
- Where it was sold
-
US Nationwide.
Nationwide
- About this recall
- NAD+ (Nicotinamide adenine dinucleotide) for Injection, a) 100 mg/mL b) 200 mg/mL, 10 mL multi-dose amber vials, GenoGenix, LLC, 2840 NW 2nd Ave Ste 204 Boca Raton, FL 33431-6692.